AC
Ampersand Capital Partners
Private EquityActiveAmpersand is a middle market private equity firm focused on investments in two core sectors: Healthcare and Industrial.
43
Investments
5
Exits
$1.5B
AUM
11.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Ampersand Capital Partners.
Investment Thesis & Strategy
Ampersand Capital Partners is a middle-market private equity firm that invests in healthcare and industrial companies across various stages. They seek to invest in companies within these sectors.
Investment Activity
Deals per year over the last 9 years
1
20150
20162
20173
20180
20190
20202
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 43 companies
V
Veralto
Healthcare · Growth, 2023
P
Precision NanoSystems
Biotech · Growth, 2021
C
Curia
Healthcare · Growth, 2021
V
Vaxart
Biotech · Growth, 2018
A
Argonaut Manufacturing Services
Healthcare · Growth, 2018
A
Advanced Instruments
Healthcare · Growth, 2018
B
BioAgilytix
Biotech · Growth, 2017
B
BioIVT
Biotech · Growth, 2017
A
Avista Pharma Solutions
Healthcare · Growth, 2015
Notable Exits
CompanyTypeYearValue / Acquirer
BioAgilytixAcquisition2021—
Avista Pharma SolutionsAcquisition2018—
Coldstream LaboratoriesAcquisition2018—
BioStorage TechnologiesAcquisition2015—
Cambridge Major LaboratoriesAcquisition2012—
Frequently Asked Questions
Ampersand Capital Partners focuses on Series B, Series C+ stage investments.
Related Investors
Gemini Investors
Wellesley, United States · 13 deals
Staley Capital
Wellesley, United States · 8 deals
Shiprock Capital
Wellesley, United States · 6 deals
Chestnut Hill Ventures
Wellesley, United States · 3 deals
GCC Investments LLC
Wellesley, United States · 3 deals
Pine Street Capital Partners
Wellesley, United States · 2 deals